AIM ImmunoTech (AIM) Misses Q2 EPS by 360c
Tweet
Share
E-mailGet Alerts AIM Hot Sheet
Join SI Premium – FREE
AIM ImmunoTech (NYSE: AIM) reported Q2 EPS of ($3.68), $3.60 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
- HSBC Downgrades IBM (IBM) to Reduce, 'Stretched Valuation'
- Mizuho Reiterates Outperform Rating on Gulfport Energy (GPOR)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
